Aloracetam is a nootropic drug closely related to the racetam family, though it lacks a pyrrolidone ring.
It was studied by Aventis for the treatment of Alzheimer’s disease but was never marketed.
Aloracetam is classified as an abandoned drug and is not assigned an ATC code. It is associated with nervous system drug research and falls under categories such as racetams, pyrroles, acetamides, and nootropics.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Aloracetam, Aloracetam [INN], N-[2-(3-formyl-2, 5-dimethylpyrrol-1-yl)ethyl]acetamide, U0RKZ75D0T |
|---|---|
| IUPAC Name | N-[2-(3-formyl-2, 5-dimethylpyrrol-1-yl)ethyl]acetamide |
| CAS | 119610-26-3 |
| Molecular Weight | 208.26 |
| Molecular Formula | C11H16N2O2 |
| SMILES | CC1=CC(=C(N1CCNC(=O)C)C)C=O |